{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/496418968",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/195467267"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#496418968",
  "code": "EB13.2",
  "source": "http://id.who.int/icd/entity/496418968",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced Stevens-Johnson and toxic epidermal necrolysis overlap syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1077457356",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1077457356"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Stevens-Johnson and toxic epidermal necrolysis overlap syndrome"
  },
  "definition": {
    "@language": "en",
    "@value": "A severe reactive skin disorder with features of both toxic epidermal necrolysis and Stevens-Johnson syndrome. It is defined by the presence of mucosal involvement and between 10% and 30% body surface area detachment of skin. It may be regarded as an intermediate form of these two disorders and, as with them, it can in most cases be attributed to a drug."
  },
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/2142927078"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Stevens-Johnson and toxic epidermal necrolysis overlap syndrome"
      }
    }
  ]
}